SB 215505
a neuroleptic with equivalent or higher antagonist affinity for 5-HT2 than for dopamine D2 receptor
Also Known As:
6-chloro-5-methyl-1-(5-quinolylcarbamoyl)indoline; SB-215505; SB215505
Networked: 5
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Jaffré, Fabrice:
2 articles
(08/2008 - 08/2004)
|
2. | Maroteaux, Luc:
2 articles
(08/2008 - 08/2004)
|
3. | Monassier, Laurent:
2 articles
(08/2008 - 08/2004)
|
4. | Borie, R:
1 article
(08/2008)
|
5. | Bousquet, Pascal:
1 article
(08/2008)
|
6. | Callebert, J:
1 article
(08/2008)
|
7. | Crestani, B:
1 article
(08/2008)
|
8. | Dehoux, M:
1 article
(08/2008)
|
9. | Fabre, A:
1 article
(08/2008)
|
10. | Hénin, D:
1 article
(08/2008)
|
Related Diseases
Related Drugs and Biologics